• Provider Login
  • Payors
  • Manufacturers
  • Blog
  • Careers
Avella Specialty Pharmacy
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact
Menu
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact

Specialty Pharmacy Insights

Return to blog

Improve Adherence with Smart Pill Bottles for Patients Taking Certain Oral Oncolytics Medications

Posted by Avella Specialty Pharmacy on Fri, Oct 7, 2016
  • Tweet

According to the Network for Excellence in Health Innovation, in the United States, poor medication adherence alone accounts for $290 billion of the annual $750 billion in wasted healthcare spend. In addition, medication non-adherence with complex oral oncolytic regiments that patients take from home can lead to ineffective treatments, hospitalizations and unnecessary disease progression.

Do your oncology patients often forget to take their medications? If so, and your patients are taking certain oral oncolytics for FDA approved indications, AdhereTech can help improve adherence and clinical outcomes. AdhereTech is a smart, wireless pill bottle equipped with lights and chimes that remind patients when it is time to take their medication. The system also makes automated phone calls to patients or caregivers if a dose is missed. Patient responses are sent to a live care team who can contact the individual in real time to ensure they are using the medication appropriately. 

AdhereTechStudy.pngTo provide additional insight on this technology with adherence, we conducted a clinical study on the effect of a "smart pill-bottle" on medication adherence in patients who have multiple myeloma and are new to lenalidomide therapy. The primary objective was to determine the difference in adherence rates between the intervention group and the control group. In the clinical study, the median adherence rate of lenalidomide patients was 100% adherence compared to 90.75% in the control group. In addition, we found that the incremental cost-effectiveness ratio estimated the cost per patient at $1,000, but it was $11,000 per year to gain one adherent patient, and an improved adherence rate of 9.25%.

How Does AdhereTech Work?

  • AdhereTech_350x520_adhere_avella.jpgZero Patient Setup: Immediately and automatically sends data from anywhere in the world
  • Reliable & Scalable: Built by one of the largest high-tech medical device manufacturers in the USA
  • Customizable Interventions: Bottle settings (automated phone calls, text messages, lights, chimes, etc.) can be adjusted and personalized
  • Easy to Use: Used just like a regular pill bottle with a standard child-resistant cap
  • Safe & Secure: Regulatory compliance is our top priority (FDA, HIPAA, CE, USP, ISO and many more)
  • 6+ Month Battery Life: Bottles are rechargeable just like cell phones, and can be used for up to 5 years

Learn more about AdhereTech for your patients to help drive patient adherence through this innovative tool.

Reach Out to Learn More

In addition, you can see the results of the recent Avella clinical study of patients using AdhereTech. The study showed 9.25% improved adherence over the control patient group and greatly improved the patients' likelihood of taking their medication within the recommended time window. Access the case study.

Topics Avella Adherence Oncology

CONNECT WITH US

  • social-twitter
  • social-linkedin
  • social-youtube
  • social-facebook
  • social-yelp

Subscribe For Updates

Recent Posts

Posts by Topic

  • Avella (28)
  • Oncology (23)
  • Specialty Pharmacy (18)
  • Hepatitis (14)
  • Adherence (12)
  • HIV/AIDS (6)
  • Medication (6)
  • Cancer (5)
  • Fertility (5)
  • limited distribution drugs (4)
  • Accreditations (3)
  • Patients (3)
  • Public Health (3)
  • Addiction Management (2)
  • Pain Management (2)
  • mobile health (2)
  • 340b Program (1)
  • Complex Disease (1)
  • Dermatology (1)
  • IG Therapy (1)
  • In the News (1)
  • Inc (1)
  • Inc 5000 (1)
  • Industry News (1)
  • Infusion Therapy (1)
  • LLS (1)
  • Managed Care (1)
  • Partners (1)
  • Pharmacist (1)
  • Psoriasis (1)
  • RSV (1)
  • Rheumatoid Arthritis (1)
  • outsourcing facility (1)
  • payers (1)
see all
  • specialty_accreditation_seal-1
  • rsz_mail_service_accreditationseal
  • Addiction Management
  • Cardiovascular Disease
  • Dermatology
  • Fertility
  • Gastroenterology
  • Hepatitis
  • HIV / AIDS
  • Infusion Therapy
  • IG Therapy
  • Multiple Sclerosis
  • Oncology
  • Ophthalmology
  • Rheumatology
  • RSV
  • Transplant
  • Urology
  • Contact Avella
  • Terms of Use
  • Privacy
  • Blog
  • 877-546-5779
© 2025 Avella Specialty Pharmacy
  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
.